United Therapeutics (UTHR) SEC Filings & 10K Form

$233.85
-2.10 (-0.89%)
(As of 04/26/2024 ET)

Recent United Therapeutics SEC Filings

DateFilerForm TypeView
04/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:07 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:56 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
5:03 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:33 PM
Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:30 PM
Klein Katherine J (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:52 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:33 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:50 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
5:03 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
3:31 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:03 AM
United Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2024
5:05 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:36 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:57 PM
ROTHBLATT MARTINE A (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
How a $0.25 cent option contract makes my top traders feel (Ad)

If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…

Click now to see for yourself what $0.25 Cent Trades is all about
02/14/2024
8:05 AM
Avoro Capital Advisors LLC (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
02/13/2024
8:50 AM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
02/08/2024
9:18 AM
United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/08/2024
5:00 AM
Celularity Inc (Subject)
Celularity Inc (Subject)
United Therapeutics (Filed by)
Form SC 13G/A
02/02/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:29 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
United Therapeutics (Subject)
Form SC 13G/A
01/18/2024
4:56 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:12 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
8:51 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC 13D
12/21/2023
3:56 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
4:00 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:53 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
4:40 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
1:06 PM
Miromatrix Medical Inc. (Issuer)
United Therapeutics (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2023
4:29 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
9:03 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-T/A
12/12/2023
3:37 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
9:52 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-T/A
12/07/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
5:00 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:01 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
5:06 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-T
11/08/2023
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
4:24 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
3:50 PM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-C
11/01/2023
5:03 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
5:05 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:06 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-C
10/30/2023
6:09 AM
Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
Form SC TO-C
10/20/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2023
4:54 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:23 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2023
3:23 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
4:12 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
4:53 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
4:19 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024
08/04/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:11 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2023
5:02 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
5:05 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
5:08 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/24/2023
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:30 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
5:30 AM
Klein Katherine J (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
5:30 AM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:UTHR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners